{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:41Z","timestamp":1793978861548,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["2023CCG03"],"award-info":[{"award-number":["2023CCG03"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH355"],"award-info":[{"award-number":["ZR2023MH355"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373776"],"award-info":[{"award-number":["82373776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119275","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:12:19Z","timestamp":1788221539000},"page":"119275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Precision chemoenzymatic tailoring of bioengineered low-molecular-weight heparins for protamine-reversible anticoagulation"],"prefix":"10.1016","volume":"319","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119275_bib1","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-024-50819-7","article-title":"Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119275_bib2","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1021\/ac501301v","article-title":"Bottom-Up low molecular weight heparin analysis using liquid chromatography-fourier transform mass spectrometry for extensive characterization","volume":"86","author":"Li","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.119275_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","article-title":"Pharmacology of heparin and related drugs: an update","volume":"75","author":"Hogwood","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2026.119275_bib4","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1021\/acs.analchem.5b02218","article-title":"Profiling analysis of low molecular weight heparins by multiple heart-cutting two dimensional chromatography with quadruple Time-of-Flight mass spectrometry","volume":"87","author":"Ouyang","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.119275_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122216","article-title":"Quality control, safety assessment and preparation approaches of low molecular weight heparin","volume":"339","author":"Yu","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib6","article-title":"Multifunctional applications and research advances of low-molecular-weight heparin","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119275_bib7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.drudis.2020.09.011","article-title":"Advances in the preparation and synthesis of heparin and related products","volume":"25","author":"Baytas","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119275_bib8","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41598-019-39093-6","article-title":"By-Products of heparin production provide a diverse source of heparin-like and heparan sulfate glycosaminoglycans","volume":"9","author":"Taylor","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119275_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/glycob\/cww104","article-title":"Surprising absence of heparin in the intestinal mucosa of baby pigs","volume":"27","author":"Yu","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmech.2026.119275_bib10","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2741\/4462","article-title":"Heparin and anticoagulation","volume":"21","author":"Linhardt","year":"2016","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2026.119275_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.14372","article-title":"Imminent risk of a global shortage of heparin caused by the African swine fever afflicting the Chinese pig herd","volume":"17","author":"Vilanova","year":"2019","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejmech.2026.119275_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119275_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/pgr2.70025","article-title":"Global use of bovine heparin: challenges and opportunities","volume":"3","author":"Oliveira","year":"2025","journal-title":"Proteoglycan Research"},{"key":"10.1016\/j.ejmech.2026.119275_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211052293","article-title":"General considerations for diversifying heparin drug products by improving the current heparin manufacturing process and reintroducing bovine sourced heparin to the US market","volume":"27","author":"Al-Hakim","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ejmech.2026.119275_bib15","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-118809","article-title":"Bovine heparin compared to porcine heparin to demonstrate bioequivalence","volume":"132","author":"Khiella","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119275_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120303","article-title":"A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin","volume":"301","author":"Zhang","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib17","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1021\/acs.orglett.3c03484","article-title":"Synthesis of anticoagulant pentasaccharide fondaparinux via 3,5-Dimethyl-4-(2\u2032-phenylethynylphenyl)phenyl glycosides","volume":"25","author":"Liu","year":"2023","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119275_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119818","article-title":"Heparin: an old drug for new clinical applications","volume":"295","author":"Wang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib19","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.jmedchem.2c02118","article-title":"Design of an ultralow molecular weight heparin that resists heparanase biodegradation","volume":"66","author":"Ham","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119275_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1207478","article-title":"Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119275_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nchembio.1459","article-title":"Homogeneous low-molecular-weight heparins with reversible anticoagulant activity","volume":"10","author":"Xu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119275_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123433","article-title":"Rationally designed chemoenzymatic synthesis of heparan sulfate oligosaccharides with neutralizable anticoagulant activity and low severe complications","volume":"357","author":"Zhang","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121881","article-title":"Advancements in heparosan production through metabolic engineering and improved fermentation","volume":"331","author":"Sheng","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib24","doi-asserted-by":"crossref","first-page":"12998","DOI":"10.1021\/ja8026345","article-title":"Solution structures of chemoenzymatically synthesized heparin and its precursors","volume":"130","author":"Zhang","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119275_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315586121","article-title":"Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin","volume":"121","author":"Douaisi","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119275_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119825","article-title":"Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase","volume":"295","author":"Yu","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/acschembio.1c00928","article-title":"Chemobiocatalytic synthesis of a low-molecular-weight heparin","volume":"17","author":"Yu","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119275_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpba.2016.12.031","article-title":"Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins","volume":"136","author":"Mauri","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2026.119275_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1073\/pnas.252643299","article-title":"Rational design of low-molecular weight heparins with improved in vivo activity","volume":"100","author":"Sundaram","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119275_bib30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/bit.22898","article-title":"K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor","volume":"107","author":"Wang","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ejmech.2026.119275_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00253-011-3231-5","article-title":"Control of the heparosan N-deacetylation leads to an improved bioengineered heparin","volume":"91","author":"Wang","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119275_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.carbpol.2015.04.002","article-title":"\u03b2-Eliminative depolymerization of the fucosylated chondroitin sulfate and anticoagulant activities of resulting fragments","volume":"127","author":"Gao","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119275_bib33","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1021\/acsomega.4c02128","article-title":"A unique enoxaparin derived from bovine intestinal heparin: a single purification step of the starting material assures a bovine enoxaparin like the standard from porcine origin","volume":"9","author":"Oliveira","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119275_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chroma.2017.09.040","article-title":"Qualitative and quantitative analysis of heparin and low molecular weight heparins using size exclusion chromatography with multiple angle laser scattering\/refractive index and inductively coupled plasma\/mass spectrometry detectors","volume":"1522","author":"Ouyang","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejmech.2026.119275_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2004.07.009","article-title":"An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research","volume":"115","author":"Wang","year":"2005","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejmech.2026.119275_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110270","article-title":"Inferior vena cava stenosis-induced deep vein thrombosis is influenced by multiple factors in rats","volume":"128","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:01:50Z","timestamp":1793977310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S0223523426007208"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119275","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision chemoenzymatic tailoring of bioengineered low-molecular-weight heparins for protamine-reversible anticoagulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119275"}}